HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Low Grade Lymphoma Clinical Trial

Official title:
High Dose Chemotherapy and Autologous or Allogeneic Blood Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Status Completed

Clinical Trial Summary

Low grade lymphoma patients receive R-ICE reinduction therapy followed by allogeneic stem cell transplanation.

Clinical Trial Description

Low grade lymphoma patients receive R-ICE reinduction therapy followed by allogeneic stem cell transplanation if they have an HLA matched sibling, or an autologous transplant if they do not. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00144092
Study type	Interventional
Source	AHS Cancer Control Alberta
Contact
Status	Completed
Phase	Phase 2
Start date	May 2001
Completion date	June 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04773769` - Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas	N/A
Completed	`NCT00791011` - Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat	Phase 1
Completed	`NCT01300026` - AMG 319 Lymphoid Malignancy FIH	Phase 1